« Back
Control ADCs for R&D
Poster Title: Control ADCs for R&D
Submitted on 28 Dec 2020
Author(s): Creative Biolabs
This poster was presented at
Poster Views: 51
View poster »

Poster Information
Abstract: In both cases, a “control ADC” with known toxicity against the same target is required to serve as positive control for the assessment of the potency of the new ADC.Summary: Once an antibody is en route as a candidate for antibody-drug conjugate (ADC) development, it is crucial to select suitable payload-linker complexes for ADC formulation and in the meantime, to develop assays that demonstrate the toxicity of the newly formed ADC.References: abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

Active lifestyle and cognitive performance in older adults
Hana Georgi, Zuzana Frydrychová

Improving the Chemical Synthesis and Performance of Extended-Length Guide RNAs for Genome Editing and Control of Gene Expression
Laurakay Bruhn, Bo Curry, Rob Kaiser, Ben Lunstad, Ryan McCaffrey, Joel Myerson, Subhadeep Roy, Daniel Ryan, Israel Steinfeld, David Taussig, Justin Townsend, Suhani Thakker, Doug Dellinger

Modulating the Activity of CRISPR-Cas with Chemical Modifications in Single-Guide RNAs
Daniel Ryan, David Taussig, Suhani Thakker, Israel Steinfeld, Ben Lunstad, Rob Kaiser, Ryan McCaffrey, Justin Townsend, Patrick Chaffey, Bo Curry, Doug Dellinger, Laurakay Bruhn

Probiocs Related Products at Creative Enzymes
Creative Enzymes

Virus-like Particles Based Vaccine Development
Creative Biolabs